Alliance for Cancer Gene Therapy

2017 Investigator’s Award in Clinical Translation of Cell and Gene Therapy for Cancer

Alliance for Cancer Gene Therapy, Inc. (ACGT) funds research aimed at furthering the development of cell and gene therapy approaches to the treatment of cancer. To this end, ACGT offers awards in Clinical Translation of Cell and Gene Therapy for Cancer, to qualified scientists at the assistant professor level and above.

 

Candidates for the 2017 Investigator’s Award in Clinical Translation of Cell and Gene Therapy for Cancer must hold an MD, PhD, or equivalent degree and must be a tenure-track or tenured faculty1. The investigator must be conducting original research as an independent faculty member. ACGT has no citizenship restrictions, and research supported by the award must be conducted at academic medical centers located in the United States or Canada.

 

The award provides up to a maximum of $500,000 distributed over 2-3 years, inclusive of a maximum of 10% indirect costs. The funds may be used at the recipient’s discretion for salary, technical assistance, supplies, animals or capital equipment, but may not support staff not directly related to the project, e.g. secretaries or administrative assistants. Purchase of equipment is not allowed in the final year of the grant. Continued support is contingent upon submission and approval of a non-competitive renewal application each year.

03-21-2017 (Abstracts)

American Association for Cancer Research

Stand Up To Cancer – Lustgarten Foundation Pancreatic Cancer Interception Dream Team

Submissions of ideas will be invited for a translational cancer research project that addresses critical problems in pancreatic cancer and positively impacts patients in the near future, with the goal of advancing innovative approaches to prevent or intercept the disease-causing process, and making data available in a format amenable to open access analytics. Prioritized areas of interest include both applied and fundamental research including: The discovery and implementation of innovative methods that effectively detects pancreatic cancer at an early and surgically curable stage; new tools for monitoring disease progression and therapeutic response, which could potentially serve as surrogate endpoints for clinical trials and regulatory approval; investigation of novel chemoprevention or immune prevention approaches; the development of risk prognostication methods for pre-invasive pancreatic neoplasms and other conditions that elucidates the molecular details underlying that increased risk; the understanding of immune suppression and inflammation mechanisms that promote pancreatic cancer and the design of methods to circumvent this; and more generally research targeted at generating sufficient knowledge to justify a clinical intervention to test novel hypotheses related to early detection and treatment of pancreatic cancer.

 

Grant Amount: $7,000,000

03-22-2017 (LOI)

Swiss Re Foundation

ReSource Award 2018

The ReSource Award focuses on social entrepreneurial approaches implementing the principles of sustainability in water management. The prize builds on more than ten years of experience in supporting outstanding partners heading for sustainable watershed management. An international jury awards $150,000 to new social entrepreneurial initiatives driving sustainable water management practices. The prize combines financial and non-financial contributions (coaching/expert advice).

03-22-2017 (Short proposal)

American Cancer Society

Research Scholar Grants

Research Scholar Grants support investigator-initiated projects across the cancer research continuum. Awards are for up to four years and for up to $165,000 per year (direct costs), plus 20% allowable indirect costs. Independent investigators in the first six years of an independent research career or faculty appointment are eligible to apply.

04-01-2017

American Cancer Society

Mentored Research Scholar Grants

Provides support for mentored research and training to full-time junior faculty, typically within the initial four years of their first independent appointment. The goal is for these beginning investigators to become independent researchers as either clinician scientists or cancer control and prevention researchers. Awards are for up to five years and for up to $135,000 per year (direct costs), plus 8% allowable indirect costs. A maximum of $10,000 per year for the mentor(s) (regardless of the number of mentors) is included in the $135,000.

04-01-2017

American Cancer Society

Postdoctoral Fellowships

This award is to support the training of researchers who have received a doctoral degree to provide initial funding leading to an independent career in cancer research (including basic, preclinical, clinical, cancer control, psychosocial, behavioral, epidemiology, health services and health policy research). Awards may be for three years with progressive stipends of $48,000, $50,000, and $52,000 per year, plus a $4,000 per year fellowship allowance (an additional $1,500 is added to the fellowship allowance in the last year to attend the ACS Postdoctoral Fellows Symposium or a domestic scientific meeting). Depending on availability of special endowment funds, the Society annually selects one or more of the top-ranked fellowships to be supplemented above the standard stipend.

04-01-2017

American Cancer Society

Institutional Research Grants

Institutional Research Grants are block grants averaging $90,000 per year for three years given to institutions as "seed money" for the initiation of projects by promising junior investigators.

04-01-2017

Autism Science Foundation

Research Accelerator Grant

The Autism Science Foundation invites applications for its Research Accelerator Grants. These grants are designed to expand the scope, speed the progress or increase the efficiency and improve final product dissemination of active autism research grants.

 

Grants of up to $5000 are available to enhance, expand and enrich grants currently funded by other sources (including ASF). Staff salary may be covered by this award. All projects must have prior IRB approval. No portion of these funds shall be used to cover indirect university costs.

04-03-2017

Cancer Research Institute

CRI Irvington Postdoctoral Fellowship Program

The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in cancer immunology.

 

The Institute seeks hypothesis-driven, mechanistic studies in both immunology and tumor immunology. The applicant and sponsor must clearly state the potential of the proposed studies to directly impact our understanding of the immune system’s role in cancer risk, tumor initiation, progression, metastasis, host response to tumors and/or the treatment of cancer.

 

The fellowship now provides an increased stipend of $55,000 for the first year, $57,000 for the second year, and $59,000 for the third year. Please note that this increase in stipend is for fellowships awarded from October 1, 2015, on and stipend levels do not change for previously awarded fellowships. In addition, an allowance of $1,500 per year is allotted to the host institution for use at the sponsor’s discretion to help pay for the fellow’s research supplies, travel to scientific meetings, and/or health insurance.

04-03-2017

American Academy of Cerebral Palsy and Developmental Medicine

Research Grants

A key mission of the Academy is to promote excellence in research for the benefit of persons with cerebral palsy and childhood-onset disabilities. One way in which the Academy promotes research is through the annual Research Grants. Grants up to $25,000 USD will be awarded.

 

Research grant funding supports high-quality, clinical research projects/programs. The award may be used to fund planning for a project or to complete a small research project of high impact in any area relevant to the AACPDM. The successful applicant will have a commitment to and track record in childhood-onset disability research.

 

Any member of the AACPDM is eligible to apply. The PI on the grant must be an AACPDM member. Only one grant application per member will be considered in a given budget year. The budget limit is $25,000 USD.

04-13-2017

Angelman Syndrome Foundation

Research Proposals

The Angelman Syndrome Foundation announces biannual calls for research proposals to be awarded in support of Angelman syndrome research. Applications will be accepted on a continual basis, with submission deadlines for subsequent review occurring annually on October 15 and April 15.

 

Angelman syndrome is a neurodevelopmental disorder caused by deficiency of the ubiquitin protein ligase UBE3A in the brain. Applications in the preclinical, translational and clinical research areas that investigate all aspects of Angelman syndrome will be considered.

 

Highest priority will be given to pilot projects to test new ideas about pathogenesis and therapeutics of Angelman syndrome, translational research and clinical research studies. Of particular interest to the ASF are studies related to communication, behavioral issues and identification of issues and treatments that impact the daily life of people with Angelman syndrome and their families. Researchers from all countries are encouraged to apply.

 

One- or two-year grants will be awarded for various amounts of up to $100,000 per year.

04-15-2017

American Diabetes Association

Innovative Basic Science (IBS)

These awards support basic research with novel and innovative hypotheses in any area relevant to the etiology or pathophysiology of diabetes and its complications that holds significant promise for advancing the prevention, cure or treatment of diabetes. Applications proposing high-risk projects with the potential for high-impact results are encouraged, as are studies that may not be sufficiently developed for traditional funding sources.

 

Awards provide up to $115,000 per year for up to three years, including indirect costs. Up to 20% of total costs may be requested for PI salary support.

04-17-2017

American Diabetes Association

Innovative Clinical or Translational Science (ICTS)

These awards support research with novel and innovative hypotheses, performed in human subjects, or research approaches to accelerate the transition of scientific discoveries into clinical application. Studies supported with these awards must directly involve human subjects, human samples and/or data, and offer considerable promise for advancing the cure, prevention or treatment of diabetes. Applications proposing high-risk projects with the potential for high-impact results are encouraged, as are studies that may not be sufficiently developed for traditional funding sources.

 

Awards provide up to $200,000 per year for up to three years, including indirect costs. Up to 20% of total costs may be requested for PI salary support.

04-17-2017

American Diabetes Association

Junior Faculty Development (JDF)

These awards support early investigators as they establish independence as diabetes researchers.

 

Awards are up to $138,000 per year for up to four years including indirect costs.PI's salary support cannot exceed $75,000 per year. Additionally, applicants can request up to $10,000 per year towards the repayment of the principal on loans for a doctoral degree (MD, PhD, PharmD, DPM or DO).

04-17-2017

American Diabetes Association

Postdoctoral Fellowship (PDF)

These fellowships are available to postdoctoral researchers (MD, MD/PhD, PhD, DVM, or equivalent) to provide support for high quality training in disciplines and topics relevant to diabetes, in an environment conducive to beginning a career in diabetes research.

 

Awards are between $47,484-$55,581/year for up to 3 years, plus yearly $5,000 training and $5,000 fringe benefit allowances. Indirect support is not allowed.

04-17-2017

American Diabetes Association

Minority Postdoctoral Fellowship (PMF)

These fellowships are available to minority postdoctoral researchers (MD, MD/PhD, PhD, DVM, or equivalent) who are underrepresented in biomedical research. Fellowships provide support for high quality training in disciplines and topics relevant to diabetes, in an environment conducive to beginning a career in diabetes research.

 

Researchers (PhD, MD, PharmD, DO, DPM, or equivalent) with confirmed postdoctoral position by award start date. Applicants must be from racial/ethnic groups that are underrepresented in biomedical research, and may not have more than 10 years research experience beyond conferral of their doctoral degree.

 

Awards are between $47,484-$55,581/year for up to 3 years, plus yearly $5,000 training and $5,000 fringe benefit allowances. Indirect support is not allowed.

04-17-2017

Cystic Fibrosis Foundation

Pilot and Feasibility Awards

These awards are for developing and testing new hypotheses and/or new methods, and supporting promising new investigators as they establish themselves in research areas relevant to cystic fibrosis. Information derived from such studies will hopefully lead to submission to other funding agencies, such as the National Institutes of Health.

 

Proposed work must be hypothesis-driven and must reflect innovative approaches to critical questions in CF research.

 

Support may be requested for $50,000 per year (plus 8 percent for indirect costs) for up to two years.

 

Priority will be placed on those projects that propose to better understand the mechanisms behind disease pathophysiology and to develop strategies to prevent or treat CF.

 

Applicants may submit only one Pilot and Feasibility Award application in 2017 (either spring or fall cycle).

04-19-2017

Cystic Fibrosis Foundation

Research Grants

Research grants are intended to support basic science research. Studies may be carried out at the subcellular, cellular, animal or patient levels. To be considered, proposals must be hypothesis-driven and provide sufficient preliminary data to justify Cystic Fibrosis Foundation support.

 

Support is available for $100,000 per year (plus 8 percent for indirect costs) for up to two years, at which time a grant may be competitively renewed for additional funding.

 

Priority will be placed on those projects that propose to better understand the mechanisms behind disease pathophysiology and to develop strategies to prevent or treat CF.

 

Applicants may submit only one Pilot and Feasibility Award application in 2017 (either spring or fall cycle).

04-19-2017

Prostate Cancer Foundation

2017 PCF Challenge Awards

The Prostate Cancer Foundation (PCF) is pleased to announce a Request for Applications for PCF Challenge Awards for investigations of metastatic, lethal prostate cancer.  These awards will be funded depending on the level of innovation in applications received.  High risk, currently unfunded projects are most desired.

 

Provide up to a total of $1 million per team.

04-24-2017

March of Dimes

2018 Research Program

MOD invites all qualified scientists with faculty appointments or the equivalent, at universities, hospitals and research institutions (not for profit or profit), to submit applications for research grants relevant to our mission: The mission of the March of Dimes is to improve the health of babies by preventing birth defects, premature birth and infant mortality. This encompasses basic biological processes governing differentiation and development involving both human and animal model systems, genetics and genomics of these processes, clinical studies, reproductive health and environmental toxicology. Social and behavioral studies are encouraged concerning cognitive and behavioral risks that affect outcomes of pregnancy, the perinatal period, and subsequent child development. The latter may involve family units and those genes, toxicants and social determinants that adversely affect language or behavior.

04-28-2017 (LOI)

Elsa U. Pardee Foundation

Research Grants

The Elsa U. Pardee Foundation funds research to investigators in United States non-profit institutions proposing research directed toward identifying new treatments or cures for cancer. The Foundation particularly encourages grant applications for a one year period which will allow establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers. It is anticipated that this early stage funding by the Foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment, or cure should be clearly identified. By design, there are no limits set on the grant amount that can be requested. It must be reasonably and clearly supported by the scope of the project outlined in the application. Applications requesting more than 15% overhead are usually not considered. Papers verifying nonprofit status and relevant human subject and experimental animal treatment approvals from the recipient institution will be requested prior to project initiation. A final report summarizing financial expenditure and research achievement is required.

04-30-2017

Lalor Foundation

The Anna Lalor Burdick Program

The Anna Lalor Burdick (ALB) Program supports programs that offer sexual and reproductive health education to young women. It is interested in programs serving young women who are disadvantaged by poverty, discrimination, geographic isolation, lack of comprehensive sex education, hostile public policy, or other factors leading to inadequate sexual and reproductive health.

 

The ALB Program is particularly interested in supporting new programs or initiatives, or innovations in successful programs. Programs at new or small organizations, including those with a grassroots base, that are capable of delivering excellent services will also be considered.

 

The ALB Program typically does not support general operations, ongoing programs, or existing staff positions.

 

The ALB Program awards a small number of grants in the range of $10,000 to $35,000, with an average grant size between $15,000 and $25,000.

 

Grants are awarded for one year.  On rare occasions, trustees invite follow-up work to a project that has shown outstanding results or promise during its first year.

05-01-2017 (Concept paper)

National Multiple Sclerosis Society

Career Transition Fellowships

Finding a way to stop MS, restore function and end MS forever will require a cadre of well-trained scientists engaged in MS-related research. The Society’s Career Transition Fellowship addresses this need by fostering the development and productivity of young scientists who have potential to make significant contributions to MS research and help ensure the future and stability of MS research. The Career Transition Fellowship targets current postdoctoral trainees who demonstrate both commitment and exceptional potential to conduct MS-related research. The award provides approximately $550,000 over five years to support a two-year period of advanced postdoctoral training in MS research and the first three years of research support in a new faculty appointment.

05-10-2017 (Preliminary application)